The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone ...
CAPTAIN randomized 211 men (2:1) with grade group 2–3, PSA ≤20 ng/mL to MRI-guided TULSA (n=148) versus robotic RP (n=63) across international centers. At 6 months, pad-free continence was 84% with ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...
A safe, easy-to-administer neuromodulation technique targets and reduces post-anesthesia agitation, offering a novel drug-free perioperative option Chinese Medical Journals Publishing House Co., Ltd.
Profound Medical Corp. has closed a $36 million registered direct offering, with proceeds earmarked to accelerate sales, marketing, and development of its AI-powered, incision-free therapeutic ...
ABSTRACT: Introduction: Benign Prostatic Hyperplasia (BPH) is one of the most common urological conditions in men over the age of fifty. Among the available therapeutic options, Transurethral ...
Radical prostatectomy in patients with a history of transurethral resection of the prostate (TUR-P) can be technically challenging due to altered surgical anatomy. This study aimed to present the ...
An enlarged prostate, known as benign prostatic hyperplasia (BPH), is a common condition often associated with the natural aging process in men. Dr. Scott Cheney, a Mayo Clinic urologist, says it's a ...
An enlarged prostate, known as benign prostatic hyperplasia (BPH), is a common condition often associated with the natural aging process in men. Dr. Scott Cheney, a Mayo Clinic urologist, says it's a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results